Bio-Rad Laboratories (BIO) Competitors $332.85 -5.92 (-1.75%) (As of 01:03 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BIO vs. MTD, WAT, ILMN, TECH, CRL, BRKR, PACB, HBIO, TMO, and AShould you be buying Bio-Rad Laboratories stock or one of its competitors? The main competitors of Bio-Rad Laboratories include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Charles River Laboratories International (CRL), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Bio-Rad Laboratories vs. Mettler-Toledo International Waters Illumina Bio-Techne Charles River Laboratories International Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Bio-Rad Laboratories (NYSE:BIO) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, profitability, valuation, institutional ownership, analyst recommendations, earnings, community ranking, risk and dividends. Does the MarketBeat Community prefer BIO or MTD? Bio-Rad Laboratories received 1 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 64.80% of users gave Bio-Rad Laboratories an outperform vote while only 56.86% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformBio-Rad LaboratoriesOutperform Votes37064.80% Underperform Votes20135.20% Mettler-Toledo InternationalOutperform Votes36956.86% Underperform Votes28043.14% Is BIO or MTD more profitable? Mettler-Toledo International has a net margin of 21.15% compared to Bio-Rad Laboratories' net margin of -30.18%. Bio-Rad Laboratories' return on equity of 3.74% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Bio-Rad Laboratories-30.18% 3.74% 2.65% Mettler-Toledo International 21.15%-531.78%24.79% Which has more volatility and risk, BIO or MTD? Bio-Rad Laboratories has a beta of 0.9, suggesting that its stock price is 10% less volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.13, suggesting that its stock price is 13% more volatile than the S&P 500. Does the media refer more to BIO or MTD? In the previous week, Mettler-Toledo International had 9 more articles in the media than Bio-Rad Laboratories. MarketBeat recorded 22 mentions for Mettler-Toledo International and 13 mentions for Bio-Rad Laboratories. Mettler-Toledo International's average media sentiment score of 1.38 beat Bio-Rad Laboratories' score of 1.28 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bio-Rad Laboratories 10 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 16 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of BIO or MTD? 65.2% of Bio-Rad Laboratories shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 17.5% of Bio-Rad Laboratories shares are owned by company insiders. Comparatively, 1.9% of Mettler-Toledo International shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has preferable earnings & valuation, BIO or MTD? Mettler-Toledo International has higher revenue and earnings than Bio-Rad Laboratories. Bio-Rad Laboratories is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBio-Rad Laboratories$2.67B3.55-$637.32M-$27.33-12.39Mettler-Toledo International$3.79B7.02$788.78M$37.0933.99 Do analysts rate BIO or MTD? Bio-Rad Laboratories currently has a consensus target price of $391.80, indicating a potential upside of 15.67%. Mettler-Toledo International has a consensus target price of $1,338.75, indicating a potential upside of 6.18%. Given Bio-Rad Laboratories' stronger consensus rating and higher possible upside, equities research analysts clearly believe Bio-Rad Laboratories is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bio-Rad Laboratories 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Mettler-Toledo International 2 Sell rating(s) 5 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 1.88 SummaryMettler-Toledo International beats Bio-Rad Laboratories on 11 of the 18 factors compared between the two stocks. Ad Porter & CompanyI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIO vs. The Competition Export to ExcelMetricBio-Rad LaboratoriesAnalytical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$9.53B$5.63B$5.24B$20.48BDividend YieldN/A0.42%5.23%3.45%P/E Ratio-12.399.7090.1936.89Price / Sales3.554.181,469.6219.15Price / Cash28.1344.0035.2522.41Price / Book1.112.605.695.72Net Income-$637.32M$515,312.50$117.66M$984.47M7 Day Performance0.14%2.45%2.86%0.64%1 Month Performance-8.06%-0.75%1.79%6.66%1 Year Performance10.33%-17.20%35.90%24.58% Bio-Rad Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIOBio-Rad Laboratories4.676 of 5 stars$332.85-1.7%$391.80+17.7%+10.3%$9.32B$2.67B-12.188,030Positive NewsMTDMettler-Toledo International3.6973 of 5 stars$1,249.07-0.2%$1,338.75+7.2%+14.2%$26.36B$3.76B33.4917,300Analyst RevisionPositive NewsWATWaters3.9272 of 5 stars$385.64+0.2%$365.85-5.1%+33.9%$22.90B$2.96B36.317,900ILMNIllumina4.7317 of 5 stars$144.15-0.1%$164.00+13.8%+32.2%$22.86B$4.50B-14.479,300Positive NewsTECHBio-Techne4.5252 of 5 stars$75.26-0.1%$81.78+8.7%+17.7%$11.96B$1.16B80.173,100Positive NewsCRLCharles River Laboratories International4.3819 of 5 stars$202.66+1.8%$214.38+5.8%-0.2%$10.36B$4.06B25.0421,800Analyst RevisionPositive NewsBRKRBruker4.9972 of 5 stars$57.93+0.1%$79.36+37.0%-11.6%$8.78B$2.96B27.869,707Short Interest ↓PACBPacific Biosciences of California1.9034 of 5 stars$1.90-0.8%$3.63+91.3%-78.3%$518.97M$173.15M-1.31730Options VolumeGap DownHBIOHarvard Bioscience2.2911 of 5 stars$2.19-0.5%N/A-50.0%$95.53M$112.25M-6.67490Short Interest ↓Positive NewsTMOThermo Fisher Scientific4.9543 of 5 stars$529.84+0.0%$649.33+22.6%+6.8%$202.66B$42.86B33.27122,000Positive NewsAAgilent Technologies4.1699 of 5 stars$139.10+0.8%$143.40+3.1%+8.4%$39.97B$6.51B31.2118,100Short Interest ↓ Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Charles River Laboratories International Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:BIO) was last updated on 12/3/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO Stock Alerts